Cigna Corporation (CI)
USD 282.41
(6.33%)
USD 282.41
(6.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.98 Billion USD | -58.49% |
| 2022 | 12.55 Billion USD | 10.33% |
| 2021 | 10.91 Billion USD | -2.09% |
| 2020 | 15.1 Billion USD | 112.4% |
| 2019 | 11.9 Billion USD | -2049.51% |
| 2018 | 4.77 Billion USD | 7.59% |
| 2017 | 4.42 Billion USD | 22.59% |
| 2016 | 3.56 Billion USD | -8.04% |
| 2015 | 3.91 Billion USD | 0.74% |
| 2014 | 3.89 Billion USD | 28.5% |
| 2013 | 2.75 Billion USD | -0.03% |
| 2012 | 3.03 Billion USD | 20.76% |
| 2011 | 2.22 Billion USD | 7.44% |
| 2010 | 2.16 Billion USD | 8.13% |
| 2009 | 2.33 Billion USD | 245.69% |
| 2008 | - USD | -65.6% |
| 2007 | 1.94 Billion USD | -5.94% |
| 2006 | 2.04 Billion USD | -18.11% |
| 2005 | 2.11 Billion USD | -4.18% |
| 2004 | 2.43 Billion USD | 106.02% |
| 2003 | 1.19 Billion USD | 442.98% |
| 2002 | - USD | -120.05% |
| 2001 | - USD | 0.64% |
| 2000 | 1.73 Billion USD | -31.32% |
| 1999 | - USD | 8.2% |
| 1998 | - USD | 22.2% |
| 1997 | - USD | 18.99% |
| 1996 | 1.6 Billion USD | 537.85% |
| 1995 | 251 Million USD | -68.82% |
| 1994 | 805 Million USD | 387.88% |
| 1993 | 165 Million USD | 7.84% |
| 1992 | 153 Million USD | -73.62% |
| 1991 | 580 Million USD | 59.34% |
| 1990 | 364 Million USD | -47.7% |
| 1989 | 696 Million USD | 22.08% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.24 Billion USD | -13.02% |
| 2024 Q2 | 2.41 Billion USD | 171.63% |
| 2024 Q3 | 2.57 Billion USD | -28.5% |
| 2023 Q2 | 2.22 Billion USD | 10.22% |
| 2023 Q3 | 2.24 Billion USD | 0.86% |
| 2023 Q1 | 2.01 Billion USD | -14.55% |
| 2023 FY | - USD | -58.49% |
| 2023 Q4 | 1.02 Billion USD | -54.06% |
| 2022 FY | - USD | 10.33% |
| 2022 Q1 | 2.55 Billion USD | 9.4% |
| 2022 Q2 | 3.03 Billion USD | 18.9% |
| 2022 Q3 | 4.5 Billion USD | 48.42% |
| 2022 Q4 | 2.35 Billion USD | -47.6% |
| 2021 Q1 | 2.53 Billion USD | -60.57% |
| 2021 Q2 | 2.91 Billion USD | 15.24% |
| 2021 Q4 | 2.33 Billion USD | -24.37% |
| 2021 Q3 | 3.08 Billion USD | 5.62% |
| 2021 FY | - USD | -2.09% |
| 2020 Q4 | 6.42 Billion USD | 126.73% |
| 2020 Q2 | 3.35 Billion USD | 35.5% |
| 2020 Q1 | 2.47 Billion USD | -3.85% |
| 2020 FY | - USD | 112.4% |
| 2020 Q3 | 2.83 Billion USD | -15.49% |
| 2019 FY | - USD | -2049.51% |
| 2019 Q4 | 2.57 Billion USD | -16.6% |
| 2019 Q1 | 3.13 Billion USD | 550.0% |
| 2019 Q3 | 3.08 Billion USD | -0.45% |
| 2019 Q2 | 3.09 Billion USD | -1.12% |
| 2018 Q4 | 482 Million USD | -59.6% |
| 2018 FY | - USD | 7.59% |
| 2018 Q3 | 1.19 Billion USD | -3.48% |
| 2018 Q2 | 1.23 Billion USD | -8.85% |
| 2018 Q1 | 1.35 Billion USD | 51.0% |
| 2017 Q2 | 1.27 Billion USD | 22.67% |
| 2017 Q4 | 898 Million USD | -6.56% |
| 2017 Q3 | 961 Million USD | -24.75% |
| 2017 FY | - USD | 22.59% |
| 2017 Q1 | 1.04 Billion USD | 36.44% |
| 2016 Q3 | 896 Million USD | -7.82% |
| 2016 Q1 | 982 Million USD | 22.6% |
| 2016 FY | - USD | -8.04% |
| 2016 Q2 | 972 Million USD | -1.02% |
| 2016 Q4 | 763 Million USD | -14.84% |
| 2015 FY | - USD | 0.74% |
| 2015 Q1 | 1 Billion USD | 13.15% |
| 2015 Q2 | 1.09 Billion USD | 8.34% |
| 2015 Q3 | 1.03 Billion USD | -5.59% |
| 2015 Q4 | 801 Million USD | -22.23% |
| 2014 FY | - USD | 28.5% |
| 2014 Q4 | 890 Million USD | -7.96% |
| 2014 Q2 | 1.04 Billion USD | 3.89% |
| 2014 Q1 | 1 Billion USD | 45.43% |
| 2014 Q3 | 967 Million USD | -7.11% |
| 2013 Q2 | 915 Million USD | 312.16% |
| 2013 FY | - USD | -0.03% |
| 2013 Q4 | 689 Million USD | -27.09% |
| 2013 Q3 | 945 Million USD | 3.28% |
| 2013 Q1 | 222 Million USD | -71.24% |
| 2012 Q2 | 799 Million USD | 7.39% |
| 2012 Q1 | 744 Million USD | 22.17% |
| 2012 FY | - USD | 20.76% |
| 2012 Q4 | 772 Million USD | -16.27% |
| 2012 Q3 | 922 Million USD | 15.39% |
| 2011 FY | - USD | 7.44% |
| 2011 Q3 | 432 Million USD | -45.39% |
| 2011 Q1 | 682 Million USD | 7.91% |
| 2011 Q2 | 791 Million USD | 15.98% |
| 2011 Q4 | 609 Million USD | 40.97% |
| 2010 Q3 | 586 Million USD | 16.04% |
| 2010 Q2 | 505 Million USD | 4.77% |
| 2010 Q1 | 482 Million USD | -15.14% |
| 2010 FY | - USD | 8.13% |
| 2010 Q4 | 632 Million USD | 7.85% |
| 2009 Q1 | 342 Million USD | 223.91% |
| 2009 Q2 | 706 Million USD | 106.43% |
| 2009 Q3 | 548 Million USD | -22.38% |
| 2009 Q4 | 568 Million USD | 3.65% |
| 2009 FY | - USD | 245.69% |
| 2008 Q4 | -276 Million USD | -192.93% |
| 2008 Q2 | 476 Million USD | 268.99% |
| 2008 Q1 | 129 Million USD | -70.34% |
| 2008 FY | - USD | -65.6% |
| 2008 Q3 | 297 Million USD | -37.61% |
| 2007 FY | - USD | -5.94% |
| 2007 Q4 | 435 Million USD | -21.34% |
| 2007 Q3 | 553 Million USD | 56.66% |
| 2007 Q2 | 353 Million USD | -26.3% |
| 2007 Q1 | 479 Million USD | 19.15% |
| 2006 Q1 | 582 Million USD | 62.12% |
| 2006 FY | - USD | -18.11% |
| 2006 Q4 | 402 Million USD | -17.96% |
| 2006 Q3 | 490 Million USD | 6.29% |
| 2006 Q2 | 461 Million USD | -20.79% |
| 2005 Q3 | 441 Million USD | -47.25% |
| 2005 Q1 | 727 Million USD | -10.69% |
| 2005 Q2 | 836 Million USD | 14.99% |
| 2005 FY | - USD | -4.18% |
| 2005 Q4 | 359 Million USD | -18.59% |
| 2004 Q3 | 575 Million USD | -30.47% |
| 2004 FY | - USD | 106.02% |
| 2004 Q1 | 250 Million USD | -47.48% |
| 2004 Q4 | 814 Million USD | 41.57% |
| 2004 Q2 | 827 Million USD | 230.8% |
| 2003 Q1 | - USD | 247.79% |
| 2003 Q4 | - USD | 35.61% |
| 2003 Q3 | - USD | 1626.09% |
| 2003 FY | - USD | 442.98% |
| 2003 Q2 | - USD | -105.85% |
| 2002 FY | - USD | -120.05% |
| 2002 Q1 | - USD | 13.87% |
| 2002 Q2 | - USD | -7.36% |
| 2002 Q3 | - USD | -434.52% |
| 2002 Q4 | - USD | 109.25% |
| 2001 Q4 | - USD | -27.16% |
| 2001 FY | - USD | 0.64% |
| 2001 Q1 | - USD | 2.35% |
| 2001 Q3 | - USD | 7.71% |
| 2001 Q2 | - USD | -7.93% |
| 2000 Q4 | - USD | -2.7% |
| 2000 Q1 | - USD | -4.42% |
| 2000 FY | - USD | -31.32% |
| 2000 Q2 | - USD | -35.92% |
| 2000 Q3 | - USD | 57.7% |
| 1999 Q1 | - USD | 11.08% |
| 1999 Q4 | - USD | -58.67% |
| 1999 Q3 | - USD | 191.06% |
| 1999 Q2 | - USD | -1.66% |
| 1999 FY | - USD | 8.2% |
| 1998 FY | - USD | 22.2% |
| 1998 Q3 | - USD | -28.6% |
| 1998 Q4 | 379 Million USD | -3.32% |
| 1998 Q2 | - USD | -35.11% |
| 1998 Q1 | - USD | 125.6% |
| 1997 Q4 | 375 Million USD | -12.18% |
| 1997 Q2 | 411 Million USD | -5.95% |
| 1997 Q1 | - USD | -5.82% |
| 1997 FY | - USD | 18.99% |
| 1997 Q3 | 427 Million USD | 3.89% |
| 1996 Q4 | 464 Million USD | 6.91% |
| 1996 Q2 | 345 Million USD | -3.63% |
| 1996 FY | - USD | 537.85% |
| 1996 Q1 | 358 Million USD | -16.36% |
| 1996 Q3 | 434 Million USD | 25.8% |
| 1995 Q1 | 402 Million USD | 58.89% |
| 1995 Q4 | 428 Million USD | 148.47% |
| 1995 Q3 | -883 Million USD | -390.46% |
| 1995 FY | - USD | -68.82% |
| 1995 Q2 | 304 Million USD | -24.38% |
| 1994 FY | - USD | 387.88% |
| 1994 Q4 | 253 Million USD | 42.13% |
| 1994 Q3 | 178 Million USD | -12.75% |
| 1994 Q2 | 204 Million USD | 20.0% |
| 1994 Q1 | 170 Million USD | -35.61% |
| 1993 Q2 | 122 Million USD | 205.0% |
| 1993 Q1 | 40 Million USD | 385.71% |
| 1993 FY | - USD | 7.84% |
| 1993 Q3 | -261 Million USD | -313.93% |
| 1993 Q4 | 264 Million USD | 201.15% |
| 1992 FY | - USD | -73.62% |
| 1992 Q2 | 161 Million USD | 9.52% |
| 1992 Q4 | -14 Million USD | 90.07% |
| 1992 Q3 | -141 Million USD | -187.58% |
| 1992 Q1 | 147 Million USD | 2.8% |
| 1991 Q1 | 48 Million USD | -61.29% |
| 1991 Q3 | 146 Million USD | -39.92% |
| 1991 Q4 | 143 Million USD | -2.05% |
| 1991 Q2 | 243 Million USD | 406.25% |
| 1991 FY | - USD | 59.34% |
| 1990 Q1 | 50 Million USD | -80.54% |
| 1990 Q4 | 124 Million USD | 663.64% |
| 1990 Q3 | -22 Million USD | -110.38% |
| 1990 Q2 | 212 Million USD | 324.0% |
| 1990 FY | - USD | -47.7% |
| 1989 Q1 | 85.5 Million USD | -39.75% |
| 1989 Q4 | 256.9 Million USD | 81.68% |
| 1989 Q2 | 144 Million USD | 68.42% |
| 1989 Q3 | 141.4 Million USD | -1.81% |
| 1989 FY | - USD | 22.08% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Centene Corporation | 5.61 Billion USD | -77.831% |
| CVS Health Corporation | 18.17 Billion USD | 45.06% |
| Elevance Health Inc. | 10.49 Billion USD | 4.795% |
| Humana Inc. | 4.93 Billion USD | -102.576% |
| Molina Healthcare, Inc. | 1.74 Billion USD | -472.649% |
| Oscar Health, Inc. | -212 Million USD | 4810.782% |
| UnitedHealth Group Incorporated | 36.33 Billion USD | 72.51% |